15,727 results on '"neurofibromatosis 1"'
Search Results
2. Natural History Study of Patients With Neurofibromatosis Type I
3. Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
4. AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors
5. Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
6. A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
7. Natural History Study of Patients With Neurofibromatosis Type 2
8. Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
9. Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
10. Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
11. Real-World Treatment Study of Koselugo (Selumetinib)
12. Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
13. MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
14. Molecular Aspects of Preimplantation Genetic Diagnosis for NF1 (NF1)
15. MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (ReNeu)
16. Pediatric Long-Term Follow-up and Rollover Study
17. Natural History Study of Cutaneous Neurofibromas in People With NF1 (cNF Natural Hx)
18. Study of Cabozantinib with Selumetinib for Plexiform Neurofibromas (NF113)
19. PASS of Paediatric Patients Initiating Selumetinib
20. Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1 (NF1NAC)
21. Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1 (DoDNAC)
22. RASopathy Biorepository
23. Evaluating Mitochondrial Dysfunction in Patients with Neurofibromatosis Type 1
24. Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 (NF114)
25. MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
26. Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
27. Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
28. Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
29. Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (SEL-TH-1601)
30. Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule
31. The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule
32. Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
33. Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery
34. US Selumetinib Registry
35. Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to (SPRINKLE)
36. Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas (KOMET)
37. NF-1, Nutraceutical Intervention
38. Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)
39. Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas (NF110)
40. Neurofibromatosis Type 1 Tumor Early Detection Study (NF1-TED)
41. Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas
42. Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1
43. Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
44. A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
45. A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1 (INSPIRE-NF1)
46. Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments
47. A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
48. Relationship Stressors in Parents of Children With Cancer or Neurofibromatosis Type 1 (NF1)
49. Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
50. HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy (cNF-HFU2101)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.